Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial

Authors: Enriqueta Felip, Nasser K. Altorki, Caicun Zhou, Eric Vallières, Alex Martínez‐Martí, Achim Rittmeyer, Antonio Chella, Martin Reck, O. Goloborodko, Meijuan Huang, R. Belleli, Virginia McNally, Minu K. Srivastava, Elizabeth Bennett, B.J. Gitlitz, H. Wakelee - Annals of Oncology 2023 cited by 251